The natural history of asthma in adults: The problem of irreversibility

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 4, 1999, Pages 539-547

  Reed, Charles E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adults; Airway remodeling; Asthma; Bronchiectasis; Cause of death; Emphysema; Lung function; Natural history; Smoking; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; GLUCOCORTICOID;

ASTHMA; BRONCHIECTASIS; CARDIOTOXICITY; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE COURSE; ELDERLY CARE; EMPHYSEMA; HUMAN; LUNG FUNCTION; LUNG PARENCHYMA; PRIORITY JOURNAL; REMISSION; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS PNEUMONIAE; TISSUE INJURY; TREATMENT OUTCOME;

EID: 0033022464     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70221-6     Document Type: Article

References (100)

1. 1. Weich DG, Samel JM. Epidemiology and natural history of asthma. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 5th ed. St Louis: Mosby, Inc; 1998. p. 769-82.
2. 2. Burrows B, Barbee RA, Cline MG, Knudson RJ, Lebowitz MD. Characteristics of asthma among elderly adults in a sample of the general population. Chest 1991;100:935-42.
3. 3. Bauer BA, Reed CE, Yunginger JW, Wollan PC, Silverstein MD. Incidence and outcomes of asthma in the elderly. A population-based study in Rochester, Minnesota. Chest 1997;111:303-10.
4. 4. Barbee RA. Epidemiology and natural history. In: Barbee RA, Bloom JW, editors. Asthma in the elderly. New York: Marcel Dekker; 1997. p. 1-32.
5. 5. Sluiter HJ, Koeter GH, de Monchy JG, Postma DS, de Vries K, Orie NG. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J 1991;4:479-89.
6. 6. US Department of Health and Human Services, Public Health Service, National Heart Lung and Blood Institute. Expert Panel report II: guidelines for the diagnosis and management of asthma; April 1997. NIH Publication No. 97-4051.
7. 7. Manfreda J, Becker AB, Wang PZ, Roos LL, Anthonisen NR. Trends in physician-diagnosed asthma prevalence in Manitoba between 1980 and 1990. Chest 1993;103:151-7.
8. 8. Pin I, Freitag AP, O'Byrne PM, Girgis-Gabardo A, Watson RM, Dolovich J, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992;145:1265-9.
9. 9. Beasley R, Burgess C, Crane J, Pearce N, Roche W. Pathology of asthma and its clinical implications. J Allergy Clin Immunol 1993;92(Pt 2):148-54.
10. 10. Toelle BG, Peat JK, Salome CM, Mellis CM, Woolcock AJ. Toward a definition nf asthma for epidemiology. Am Rev Respir Dis 1992;146:633-7.
11. 11. Venables KM, Farrer N, Sharp L, Graneek BJ, Newman Taylor AJ. Respiratory symptoms questionnaire for asthma epidemiology: validity and reproducibility. Thorax 1993;48:214-9.
12. 12. Wiggs DR, Bosken C, Pare PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:1251-8.
13. 13. Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992;146:177-84.
14. 14. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ III, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma. Incidence rates, 1964. Am Rev Respir Dis 1992;146:888-94.
15. 15. Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980;122:567-75.
16. 16. Dodge R, Cline MG, Lebowitz MD, Burrows B. Findings before the diagnosis of asthma in young adults. J Allergy Clin Immunol 1994;94:831-5.
17. 17. Lebowitz MD, Bronnimann S, Camilli AE. Asthmatic risk factors and bronchial reactivity in non-diagnosed asthmatic adults. Eur J Epidemiol 1995;11:541-8.
18. 18. Sherrill DL, Lebowitz MD, Halonen M, Barbee RA, Burrows B. Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med 1995;152:98-102.
19. 19. Peat JK, Toelle BG, Dermand J, van den Berg R, Britton WJ, Woolcock AJ. Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study. Allergy 1996;51:804-10.
20. 20. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996;312:1195-9.
21. 21. Kaplan BA, Mascie-Taylor CG. Smoking and asthma among 23-year-olds. J Asthma 1997;34:219-26.
22. 22. Meredith S. Reported incidence of occupational asthma in the United Kingdom, 1989-90. J Epidemiol Community Health 1993;47:459-63.
23. 23. Beckett WS. The epidemiology of occupational asthma. Eur Respir J 1994;7:161-4.
24. 24. Kogevinas M, Anto JM, Soriano JB, Tobias A, Burney P. The risk of asthma attributable to occupational exposures. A population-based study in Spain. Spanish Group of the European Asthma Study. Am J Respir Crit Care Med 1996;154:137-43.
25. 25. Sunyer J, Anto JM, Sabria J, Rodrigo MJ, Roca J, Morell F, et al. Risk factors of soybean epidemic asthma. The role of smoking and atopy. Am Rev Respir Dis 1992;145:1098-102.
26. 26. Anto JM, Sunyer J, Rodriguez-Roisin R, Suarez-Cervera M, Vazquez L. Community outbreaks of asthma associated with inhalation of soybean dust. Toxicoepidemiological Committee. N Engl J Med 1989;320:1097-102.
27. 27. Burrows B, Lebowitz MD, Barbee RA, Cline MG. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol 1991;88:870-7.
28. 28. Sunyer J, Anto JM, Castellsague J, Soriano JB, Roca J. Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma. Eur Respir J 1996;9:1880-4.
29. 29. Tollerud DJ, O'Connor GT, Sparrow D, Weiss ST. Asthma, hay fever, and phlegm production associated with distinct patterns of allergy skin test reactivity, eosinophilia, and serum IgE levels. The Normative Aging Study. Am Rev Respir Dis 1991;144:776-81.
30. 30. Almind M, Viskum K, Evald T, Dirksen A, Kok-Jensen A. A seven-year follow-up study of 343 adults with bronchial asthma. Dan Med Bull 1992;39:561-5.
31. 31. Sunyer J, Anto JM, Sabria J, Roca J, Morell F, Rodriguez-Roisin R, et al. Relationship between serum IgE and airwray responsiveness in adults with asthma. J Allergy Clin Immunol 1995;95:699-706.
32. 32. Paoletti P, Prediletto R, Carrozzi L, Viegi G, Di Pede F, Carmignani G, et al. Effects of childhood and adolescence-adulthood respiratory infections in a general population. Eur Respir J 1989;2:428-36.
33. 33. Eschenbacher WL, Holian A, Campion RJ. Air toxics and asthma: impacts and end points. Environ Health Perspect 1995;103(Suppl 6):209-11.
34. 34. Castellsague J, Sunyer J, Saez M, Anto JM. Short-term association between air pollution and emergency room visits for asthma in Barcelona. Thorax 1995;50:1051-6.
35. 35. Krzyzanowski M, Lebowitz MD. Changes in chronic respiratory symptoms in two populations of adults studied longitudinally over 13 years. Eur Respir J 1992;5:12-20.
36. 36. Sparrow D, O'Connor GT, Basner RC, Rosner B, Weiss ST. Predictors of the new onset of wheezing among middle-aged and older men. The Normative Aging Study. Am J Respir Dis 1993;147:367-71.
37. 37. Lebowitz MD, Postma DS, Burrows B. Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitis. Chest 1995;108:55-61.
38. 38. Ronmark E, Lundback B, Jonsson E, Jonsson AC, Lindstrom M, Sandstrom T. Incidence of asthma in adults - report from the Obstructive Lung Disease in Northern Sweden Study. Eur J Allergy Clin Immunol 1997;52:1071-8.
39. 39. Forastiere F, Balmes J, Scarinci M, Tager JB. Occupation, asthma, and chronic respiratory symptoms in a community sample of older women. Am J Respir Crit Care Med 1998;157:1864-70.
40. 40. O'Connor GT, Sparrow D, Segal MR, Weiss ST. Smoking, atopy, and methacholine airway responsiveness among middle-aged and elderly men. The Normative Aging Study. Am J Respir Dis 1989;140:1520-6.
41. 41. Sunyer J, Anto JM, Kogevinas M, Soriano JB, Tobias A, Munoz A. Smoking and bronchial responsiveness in nonatopic and atopic young adults. Spanish Group of the European Study of Asthma. Thorax 1997;52:235-8.
42. 42. Sherrill DL, Halonen M, Burrows B. Relationships between total serum IgE, atopy, and smoking: a twenty-year follow-up analysis. J Allergy Clin Immunol 1994;94:954-62.
43. 43. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am J Respir Dis 1989;140:1527-37.
44. 44. Rimpela AH, Savonius B, Rimpela MK, Haahtela T. Asthma and allergic rhinitis among Finnish adolescents in 1977-1991. Scand J Soc Med 1995;23:60-5.
45. 45. Broder I, Higgins MW, Mathews KP, Keller JB. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. IV. Natural history. J Allergy Clin Immunol 1974;54:100-10.
46. 46. Dodge RR, Burrows B. The prevalence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980; 122:567-75.
47. 47. Campbell K, Davis J, Kingston H, Milne GA. An all age group study of the prevalence of asthma in Golden Bay. N Z Med J 1993;106:282-3.
48. 48. Ertle AR, London MR. Insights into asthma prevalence in Oregon. J Asthma 1998;35:281-9.
49. 49. Prescott E, Lange P, Vestbo J. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen City Heart Study Group. Thorax 1997;52:287-9.
50. 50. Evans R, Mullaly DI, Wilson RW, Gergen DJ, Rosenberg HM, Chevanley IM, et al. National trends in the morbitidy and mortality of asthma in the United States. Prevalence, hospitalization, and mortality of asthma over two decades: 1965-1984. Chest 1987;91:65s-74s.
51. 51. Vergnenëgre A, Antonini MT, Bonnaud F, Melloni B, Mignonat G, Bousquet J. Comparison between late onset and childhood asthma. Allergol Immunopathol (Madrid) 1992;20:190-6.
52. 52. Rackemann FM, Edwards MC. Is intrinsic asthma a reversible disease? Allergy 1958;29:528-36.
53. 53. Samter M, Beers RE. Intolerance to aspirin. Ann Intern Med 1968;68:975-82.
54. 54. Bronnimann S, Burrows B. A prospective study of the natural history of asthma. Remission and relapse rates. Chest 1986;90:480-4.
55. 55. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-9.
56. 56. Annesi I, Oryszczyn MP, Frette C, Neukirch F, Orvoen-Frija E, Kauffmann F. Total circulating IgE and FEV1 in adult men. An epidemiologic longitudinal study. Chest 1992;101:642-8.
57. 57. Ulrik CS, Backer V, Dirksen A. Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. J Asthma 1992;29:29-38.
58. 58. Dompeling E, van Schayck CP, van Grunsven PM, van Herwaarden CL, Akkermans R, Molema J, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993;118:770-8.
59. 59. Boulet LP, Jobin C, Milot J, Turcotte H. Five-year changes in airflow obstruction and airway responsiveness in mild to moderate asthma. Clin Invest Med 1994;17:432-42.
60. 60. Postma DS, Lebowitz MD. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults. Arch Intern Med 1995;155:1393-9.
61. 61. Gerritsen J, Koëter GH, de Monchy JG, Knol K. Allergy in subjects with asthma from childhood to adulthood. J Allergy Clin Immunol 1990;85:116-25.
62. 62. Frette C, Annesi I, Korobaeff M, Neukirch F, Dore MF, Kauffmann F. Blood eosinophilia and FEV1. Cross-sectional and longitudinal analyses. Am J Respir Dis 1991;143:987-92.
63. 63. Cline MG, Dodge R, Lebowitz MD, Burrows B. Determinants of percent predicted FEV1 in current asthmatic subjects. Chest 1994;106:1089-93.
64. 64. Weiss ST, O'Connor GT, Demolles D, Platts-mills T, Sparrow D. Indoor allergens and longitudinal FEV1 decline in older adults - the normative aging study. J Allergy Clin Immunol 1998;101:720-5.
65. 65. Chan-Yeung M, Lam S, Koener S. Clinical features and natural history of occupational asthma due to western red cedar (Thuja plicata). Am J Med 1982;72:411-5.
66. 66. Chan-Yeung M, MacLean L, Pagiaro PL. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol 1987;79:292-6.
67. 67. Lam S, Chan-Yeung M. Occupational asthma: natural history, evaluation and management. Occup Med 1987;2:373-81.
68. 68. Malo JL, Ghezzo H, D'Aquino C, L'Archeveque J, Cartier A, Chan-Yeung M. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol 1992;90:937-44.
69. 69. Pisati G, Baruffini A, Zedda S. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br J Med 1993;50:60-4.
70. 70. Brugnami G, Marabini A, Siracusa A, Abbritti G. Work-related late asthmatic response induced by latex allergy. J Allergy Clin Immunol 1995;96:457-64.
71. 71. Gassert TM, Hu H, Kelsey KT, Christiani DC. Long-term health and employment outcomes of occupational asthma and their determinants. J Occup Environ Med 1998;40:481-91.
72. 72. O'Connor GT, Sparrow D, Weiss ST. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Dis 1989;140:225-52.
73. 73. Sobonya RE. Quantitative structural alterations in long-standing allergic asthma. Am J Respir Dis 1984;130:289-92.
74. 74. Jeffery PK. Pathology of asthma: a comparison with COPD. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 5th ed. St. Louis: Mosby, Inc.; 1998. p. 867-76.
75. 75. Boulet L, Belanger M, Carrier G. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med 1995;152:865-71.
76. 76. Okazawa M, Muller N, McNamara AE, Child S, Verburgt L, Pare PD. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit Care Med 1996;154:1557-62.
77. 77. Bousquet J, Lacoste JY, Chanez P, Vic P, Godard P, Michel FB. Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med 1996;153:1648-54.
78. 78. Godfrey RW, Lorimer S, Majumdar S, Adelroth E, Johnston PW, Rogers AV, et al. Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment. Eur Respir J 1995;8:922-7.
79. 79. Vignola AM, Chanez P, Chiappara G, Gagliardo R, Bonsignore G, Bousquet J. Growth factors in the remodeling of asthma. Allergy Clin Immunol Int 1998;10:149-53.
80. 80. Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986;146:916-8.
81. 81. Paganin F, Trussard V, Seneterre E, Chanez P, Giron J, Godard P, el al. Chest radiography and high resolution computed tomography of the lungs in asthma. Am J Respir Dis 1992;146:1084-7.
82. 82. Paganin F, Seneterre E, Chanez P, Daures JP, Bruel JM, Michel FB, et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996;153:110-4.
83. 83. Park JW, Hong YK, Kim CW, Kim DK, Choe KO, Hong CS. High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Invest Allergol Clin Immunol 1997;7:186-92.
84. 84. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995;8:1694-8.
85. 85. Kondoh Y, Taniguchi H, Yokoyama S, Taki F, Takagi K, Satake T. Emphysematous change in chronic asthma in relation to cigarette smoking. Assessment by computed tomography. Chest 1990;97:845-9.
86. 86. Mochizuki T, Nakajima H, Kokubu F, Kushihashi T, Adachi M. Evaluation of emphysema in patients with reversible airway obstruction using high-resolution CT. Chest 1997;112:1522-6.
87. 87. Jenkins MA, Hurley SF, Jolley DJ, Oliver RG, McLean AJ, McNeil JJ. Trends in Australian mortality of asthma, 1979-1985. Med J Aust 1988;149:620-4.
88. 88. Schenker MB, Gold EB, Lopez RL, Beaumont JJ. Asthma mortality in California, 1960-1989. Demographic patterns and occupational associations. Am Rev Respir Dis 1993;147:1454-60.
89. 89. Silverstein MD, Reed CE, O'Connell EJ, Melton LJ III, O'Fallon WM, Yunginger JW. Long-term survival of a cohort of community residents with asthma. N Engl J Med 1994;331:1537-41.
90. 90. Toren K, Lindholm NB. Do patients with severe asthma run an increased risk from ischaemic heart disease? Int J Epidemiol 1996;25:617-20.
91. 91. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 1996;347:1285-9.
92. 92. Hunt LW Jr, Silverstein MD, Reed CE, O'Connell EJ, O'Fallon WM, Yunginger JW. Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA 1993;269:1947-52.
93. 93. Jenkins MA, Rubinfeld AR, Robertson CF, Bowes G. Accuracy of asthma death statistics in Australia. Aust J Pub Health 1992;16:427-9.
94. 94. Smyth ET, Wright SC, Evans AE, Sinnamon DG, MacMahon J. Death from airways obstruction: accuracy of certification in Northern Ireland. Thorax 1996;51:293-7.
95. 95. Model D. Preventable factors and death certification in death due to asthma. Respir Med 1995;89:21-5.
96. 96. Wright SC, Evans AE, Sinnamon DG, MacMahon J. Asthma mortality and death certification in Northern Ireland. Thorax 1994;49:141-3.
97. 97. Campbell DA, McLennan G, Coates JR, Frith PA, Gluyas PA, Latimer KM, et al. Accuracy of asthma statistics from death certificates in South Australia. Med J Aust 1992;156:860-3.
98. 98. Bremner P, Burgess CD, Crane J, McHaffie D, Galletly D, Pearce N, et al. Cardiovascular effects of fenoterol under conditions of hypoxaemia. Thorax 1992;47:814-7.
99. 99. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1,075 outpatients with asthma. Chest 1995;108:10-5.
100. 100. Fleming JS, Halson P, Conway J, Moore E, Nassim MA, Hashish AH, et al. Three-dimensional description of pulmonary deposition of inhaled aerosol using data from multimodality imaging. J Nucl Med 1996;37:873-7.